ABUSvs its industry peers
A metric-by-metric comparison of ABUS against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABUSThis | $1.0B#3 | 6.4x#5 | 3.9x#4 | 71.1x#4 | 128.2%#1 | 52.1%#1 | -271.0%#1 | -12.9%#1 | — | — | — | — |
| CDTTW | $5271#7 | 0.0x#2 | 0.0x#1 | — | — | -120.3%#5 | — | -38.0%#2 | — | — | — | — |
| ASBPW | $32259#4 | 0.0x#3 | 0.0x#3 | 5.2x#2 | — | -1768.9%#6 | -312016.9%#3 | -208.2%#6 | — | — | -56.3%#3 | — |
| REVBW | $24697#5 | 0.0x#4 | 0.0x#2 | — | — | 40.7%#2 | — | -88.5%#3 | — | — | -43.6%#1 | — |
| ADTX | $7588#6 | 0.0x#1 | — | 2.4x#1 | -97.6%#3 | -6.8%#4 | -612542.2%#4 | — | — | — | -100.0%#5 | — |
| AAPG | $6.5B#2 | — | 179.1x#5 | 52.1x#3 | — | — | — | -153.5%#5 | — | — | -55.2%#2 | — |
| AKTX | $1.62T#1 | — | 86904.8x#6 | 4392758.3x#5 | -39.5%#2 | 12.6%#3 | -4695.9%#2 | -93.0%#4 | -155.6%#1 | — | -66.4%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice